It gives me great pleasure to write this letter to you at the end of
the year when we have put the company on its path to a bright future.
The last year has been a year of great achievements in creating the
infrastructure and putting together the roadmap.
We manufactured the prototype of the B-P Knee Replacement System in
Cobalt-Chromium with indigenous technology maintaining complete
compliance with the exacting specifications as per the licensed
technology from Endotec Inc., USA
We performed the first knee replacement surgery successfully at Baby
Memorial Hospital, Calicut
We became the first company in India to release an FDA approved design
in Total Knee Replacement Systems.
We successfully implemented Total Quality Management and completed the
CE certification requirements
We completed the Indian Drug Control license requirements
We have successfully completed 31 knee replacement surgeries using our
B-P High Flex Knee system by the end of our financial year.
Overall, we have been a pioneer in India by introducing an indigenously
manufactured leading edge, world- class knee replacement system and are
striving to put the company on the path to being a complete orthopedic
solutions provider in the future. Our roadmap has a complete range of
orthopedic products such as the hip, shoulder and ankle replacement
systems, which we will be launching in the near future.
This past year, we have built a foundation on which we can grow and
will use this coming year to establish ourselves well in South India.
We will start the marketing efforts in Northern India by the end of the
year and also will start the efforts of exporting our products into the
countries in which we have exclusive marketing rights of the B-P range
of products. We are looking at growing a whopping 300% to 400% in the
next year. As we execute on our plans and achieve accelerated growth, I
am confident that the investors will be able to experience the benefits
of the higher valuation of the equity that they hold in the company.